Throat Cancer Market Research Report- Forecast to 2030

Throat Cancer Market Information, by Types (Pharyngeal Cancer and Laryngeal Cancer), Treatments (Surgery, Radiation Therapy, Chemotherapy, Others) - Forecast to 2030

ID: MRFR/Pharma/1260-HCR | December 2022 | Region: Global | 80 Pages         

Throat Cancer Market

The throat cancer market is projected to grow at Cagr 8.4% during the forecast 2022-2030

Segmentation

By Types Pharyngeal Cancer and Laryngeal Cancer
By Treatments Surgery Radiation Therapy Chemotherapy

Key Players

  • Amgen Inc.
  • Celgene Corporation
  • Eli Lilly and Company
  • Engeneic Ltd
  • Bristol-Myers Squibb
  • Hoffmann-la Roche AG
  • Merck & Co. Inc.
  • Moderna Inc.
  • Novartis
  • eTheRNA

Drivers

  • The expanding elderly population is a primary driver of the Throat Cancer Market Outlook
  • The prevalence of throat cancer
Speak to Analyst Request a Free Sample

Throat Cancer Market Overview


The Throat Cancer Market is projected to reach USD 4,400 Million by 2030 at 8.4% CAGR during the forecast period 2022-2030.Cancer is a disease in which abnormal cells in the body replicate and divide erratically. Tumors are formed when aberrant cells combine to generate a dangerous development. Throat cancer is a type of cancer that affects the voice box, vocal cords, and various regions of the throat, such as the tonsils and oropharynx. Throat cancer is a form of head and neck cancer that affects the larynx and other parts of the throat. The squamous cells that line the mouth, nose, and throat are the most common sites for head and neck cancer. A chronic sore throat, difficulty swallowing, unhealed mouth sores, a raspy voice, and persistent enlargement of the neck from swollen lymph nodes are all common symptoms. Cough, change in voice, painful throat, earache, and difficulty swallowing are just a few of the signs of throat cancer. There are two types of throat cancer: pharyngeal cancer and laryngeal cancer.


During the historic forecast period, approximately 157,000 new cases of laryngeal cancer were detected worldwide. Around 1.1 percent of adults will be diagnosed with pharyngeal cancer and 0.4 percent with laryngeal cancer at some point in their lives. Tobacco usage, heavy alcohol intake, HPV infection, and chewing betel juice are the leading causes of throat cancer. According to the American Cancer Society, 13,430 new cases of laryngeal cancer were discovered during the historic throat cancer market Forecast period, with 79 percent of males and 21% of women being diagnosed. Men are more likely than women to develop throat cancer, which is likely due to their smoking habits. These all reasons have at some palace and somehow increased the market size.


COVID Analysis


The COVID-19 pandemic had a significant influence on trade and industry. Manufacturers are revamping their product offerings and developing new items to recover from the existing situation. The duration of the pandemic's propagation is still a key factor in assessing the pandemic's overall impact. However, the global Throat Cancer market is expected to stabilize after 2021. Cancer is a disease in which abnormal cells in the body replicate and divide erratically. Tobacco usage, heavy alcohol intake, HPV infection, and chewing betel juice are the leading causes of market growth. As a result, throughout the market forecast.


Throat Cancer Market Dynamics


Drivers


The expanding elderly population is a primary driver of the Throat Cancer Market Outlook. The prevalence of throat cancer, alcohol consumption, and an increase in HPV infections are the primary reasons driving the growth of the market in the forecast period, with an increase in the smoking population in emerging countries. Increasing disposable incomes, which leads to an increase in people's healthcare spending, increased demand for diagnostic imaging, advancements in treatment techniques, and the inclusion of novel technologies in diagnostic equipment will all contribute to market value.


Restraints


A lack of targeted/specific medications to treat throat cancer, as well as the side effects of standard chemotherapy drugs and a lack of adequate illness detection, are some of the challenges that may stymie the throat cancer market share shortly. The low adoption rate of digital technology-based systems, traditional CT and MRI scanners, excise duty placed on the sale of medical devices in mature markets, a shortage of skilled experts to operate the instruments, high treatment costs, and a lack of public awareness are also the major reasons for the restaining of the market.


Because of technological developments and advanced research, the Throat Cancer market has a lot of promise. Companies are focusing on throat cancer diagnosis and therapy, as well as novel treatments. CT scans, PET scans, needle biopsy, MRI scans, thoracoscopy, and mediastinoscopy are presently used to diagnose throat cancers. Additionally, the principal therapeutic options for throat cancer removal include surgery and chemotherapy. The technique and process of making visual representations of the interior of a body for clinical examination and medical intervention, as well as visual representations of the function of specific organs or tissues, is known as medical imaging (physiology). The squamous cells that line the mouth, nose, and throat are the most common sites for throat cancer. Head MRI, CT of the sinuses, head CT, panoramic dental x-ray, dental cone beam CT, PET/CT, or chest imaging are some of the most common methods used to confirm a cancer diagnosis and assess if it has spread.


Study Objectives


The study provides for the complete structure of the market, as well as forecasts for the main segments and sub-segments of the market, and also gives information on the elements that influence the growth of the market.


The objective of the study is to provide a competitive landscape for the throat cancer market by providing an overview of key companies and their strategic profiling in the market, completely analyzing their core strengths, and developing a competitive landscape.


Throat Cancer Market Segment Overview


Based on the types, the Market has been segmented as follows:



  • Pharyngeal Cancer

  • Laryngeal Cancer


Based on the treatment types, the Market has been segmented as follows:



  • Surgery

  • Radiation Therapy

  • Targeted Therapy

  • Chemotherapy

  • Antimetabolites

  • Platinum Derivatives

  • Plant derivatives

  • Nitrogen Mustards

  • Antibiotics

  • Others


Based on end-user, the Market has been segmented as follows:



  • Hospitals

  • Cancer Research Institutes

  • Multispecialty Clinics

  • Ambulatory Surgical Centers


Throat Cancer Market Regional Classification


North America has the largest throat cancer market in the world. Throat cancer accounts for about 4% of all malignancies in the United States, according to the National Health Institute. Men are found to be more than twice as likely as women to have this sort of cancer. During the historic forecast period, more than 65,000 men and women in the United States were diagnosed with throat cancer, according to the researchers. As a result, the market's expansion will be aided by this massive disease burden. Europe is the second-largest market for throat cancer after the United States, and it is predicted to increase quickly in the coming years. Diagnostic imaging is in higher demand, and treatment models are seeing breakthroughs and innovations, all of which contribute to the overall market's growth. The Asia-Pacific region is predicted to develop at the quickest rate in the throat cancer market. As a result, the growing elderly population worldwide, as well as government and private sector initiatives, are some of the main drivers driving the market forward.


Throat Cancer Market Competitive Landscape


The majority of throat cancer testing equipment is produced by global major vendors. Industry leaders have built their position in the market by investing more in research and having a better distribution system. Furthermore, due to increased awareness, some small players are emerging throughout Asia-Pacific. This has also aided the market's expansion. The major key players of the market are as follows:



  • Amgen Inc.

  • Celgene Corporation

  • Eli Lilly and Company

  • Engeneic Ltd

  • Bristol-Myers Squibb

  • Hoffmann-la Roche AG

  • Merck & Co., Inc.

  • Moderna Inc.

  • Novartis

  • eTheRNA

  • Pfizer Inc.

  • Teva Pharmaceutical Industries Ltd

  • Others


Recent Developments


The European Commission awarded eTheRNA, a Belgian immunotherapy business, a EUR 6.9 million grant to speed the clinical development of mRNA-based vaccinations for throat cancer.


Moderna Inc. released interim results from the expansion cohort of its ongoing Phase 1 study of its mRNA personalized cancer vaccine (PCV) mRNA-4157 in combination with Merck's Keytruda, showing that the vaccine candidate is well tolerated at all dose levels and produces responses as measured by tumor shrinkage in HPV (-)Head and Neck Squamous Cell Carcinoma (HNSCC) patients.


Throat Cancer Market Report Overview


The Global Throat Cancer Market research report provides an in-depth analysis of emerging trends, market drivers, technology analysis, and market constraints that may influence the industry's market dynamics. Its in-depth market segment study includes kinds, applications, and competitor analysis. The research looks at regional consumer and technical trends, as well as recent industry dynamics. The research looks at the numerous elements that influence market dynamics, as well as key and connected industries, and helps firms comprehend different client propositions. This intelligence report is the result of intensive study and analysis of the many market growth variables.



Report Scope:

Report Attribute/Metric Details
  Market Size   USD 4,400 Million
  CAGR   8.4%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Treatments,
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Amgen Inc., Bristol-Myers Squibb, Celgene Corporation, Eli Lilly and Company, Engeneic Ltd, F. Hoffmann-la Roche AG, Merck & Co., Inc., Novartis, Pfizer Inc., Teva Pharmaceutical Industries Ltd and Others
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers   Growing aging population


Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

The outlook of throat cancer market looks very promising.

Rising prevalence of throat cancer and the emergence of new drugs and therapies for the treatment are the major tailwinds pushing the growth of the global throat cancer market.

North America holds the largest share in the global throat cancer market, followed by Europe and the Asia Pacific, respectively.

Bristol-Myers Squibb, Amgen Inc., Celgene Corporation, Engeneic Ltd, Eli Lilly and Company, F. Hoffmann-la Roche AG, Novartis, Merck & Co., Inc., Pfizer Inc., and Teva Pharmaceutical Industries Ltd., are some of the major players operating in the throat cancer market.

Strategic initiatives such as mergers & acquisitions, collaborations, expansion, and technology/ product launch are some of the growth strategies that players operating in the global throat cancer market adopt to gain a larger competitive advantage.